Urinary incontinence in women;Incontinencia de orina en la mujer

Medicina Clinica

Volumn 120, Issue 12, 2003, Pages 464-472

  Espuña Pons, Montserrat ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CAFFEINE; DIURETIC AGENT; HYPNOTIC SEDATIVE AGENT; NEUROLEPTIC AGENT;

ARTICLE; DISEASE CLASSIFICATION; FEMALE; HUMAN; NOCTURNAL ENURESIS; SYMPTOMATOLOGY; URINALYSIS; URINARY URGENCY; URINE INCONTINENCE;

EID: 0037987807     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13045525     Document Type: Article

References (44)

1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology in lower urinary tract function. Report from the Standardisation Sub-committee of the International Continence Society. Neurourol and Urodyn 2002;21:167-78.
2. Hunskaar S, Arnold EP, Burgio K, Diokno AC, Herzog AR, Mallett VT. Epidemiology natural history of urinary incontinence. Int Urogynecol J 2000;11:301-19.
3. Hampel C, Wienhold D, Benken N, Eggersmann C, Thuroff JW. Prevalence and natural history of female incontinence. Eur Urol 1997;32(Suppl 2):3-12.
4. Thomas TM, Plymat KR, Blannin J, Meade TW. Prevalence of urinary incontinence. BMJ 1980;281:1243.
5. Locher JL, Burgio KL, Goode PS, Roth DL, Rodríguez E. Effects of age and causal attribution to aging on health-related behaviors associated with urinary incontinence in older women. Gerontologist 2002;42:515-21.
6. Benassi L, Bocchialini E, Bertelli M, Kaihura CT, Ricci L, Siliprandi V. Risk of genital prolapse and urinary incontinence due to pregnancy and delivery. A prospective study. Minerva Ginecol 2002;54:317-24.
7. Pregazzi R, Sartore A, Troiano L, Grimaldi E, Bortoli P, Siracusano S, et al. Postpartum urinary symptoms: prevalence and risk factors. Eur J Obstet Gynecol Reprod Biol 2002;103:179-82.
8. Greydanus DE, Patel DR. The female athlete. Before and beyond puberty. Pediatr Clin North Am 2002;49:553-80.
9. Hunskaar S, Vinsnes A. The quality of life in women with urinary incontinence as measured by the sickness impact profile. J Am Geriatr Soc 1991;39: 378-82.
10. Grimby A, Milsom I, Molander U, Wiklund I, Ekelund P. The influence of urinary incontinence on the quality of life of elderly women. Age Ageing 1993;22:82-9.
11. Bidmead J, Cardozo L, McLellan A, Khullar V, Kelleher C. A comparison of the objective and subjective outcomes of colposuspension for stress incontinence in women. Br J Obstet Gynaecol 2001;108:408-13.
12. Dmochowski RR, Davila GW, Zinner NR, Gittelman MC, Saltzstein DR, Lyttle S, et al. Efficacy and safety of transdermal oxybutynin in patients with urge and mixed urinary incontinence. J Urol 2002;168:580-6.
13. Moore KH, Simons A, Dowell C, Bryant C, Prashar S. Efficacy and user acceptability of the urethral occlusive device in women with urinary incontinence. J Urol 1999;162:464-8.
14. Vinker S, Kaplan B, Nakar S, Samuels G, Shapira G, Kitai E. Urinary incontinence in women: prevalence, characteristics and effect on quality of life. A primary care clinic study. Isr Med Assoc J 2001;3:663-6.
15. International Classification of Functioning, Disability and Health -ICIDH-2. Disponible en: http://www.who.int/icidh
16. Abrams P, Cardozo L, Khoury S, Wein A. Incontinence. Recommendations of International Scientific Committee. Evaluation and treatment of urinary incontinence, pelvic organ prolapse and faecal incontinence. Second International Consultation on Incontinence. Edition 2002. Plymbridge Distributors Ltd, 2002; p. 1079-117.
17. Jackson S, Donovan J, Brookes S, Eckford S, Swithinbank L, Abrams P. The Bristol Female Lower Urinary Tract Symptoms questionnaire: development and psychometric testing. Br J Urol 1996;77:805-12.
18. Harvey MA, Kristjansson B, Griffith D, Versi E. The Incontinence Impact Questionnaire and the Urogenital Distress Inventory: a revisit of their validity in women without a urodynamic diagnosis. Am J Obstet Gynecol 2001;185:25-31.
19. Kelleher CJ, Cardozo LD, Khullar V, Salvatore S. A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol 1997;104:1374-9.
20. Badia X, Castro D, Conejero J. Validez del cuestionario King's Health para la evaluación de la calidad de vida en pacientes con incontinencia urinaria. Med Clin (Barc) 2000;114:647-52.
21. Lacima G, Espuña M, Pera M, Puig-Clota M, Quintó LL, García-Valdecasas JC. Clinical, urodynamic, and manometric findings in women with combined fecal and urinary incontinence. Neurourol Urodyn 2002;21: 464-9.
22. Jensen JK, Nielsen F, Ostegar D. The rol of patient history in the diagnosis of urinary incontinence. Obstet Gynecol 1994;83:904-10.
23. James M, Jackson S, Shepherd A, Abrams P. Pure stress leakage symptomatology: is it safe to discount detrusor instability? Br J Obstet Gynaecol 1999;106:1255-8.
24. Harvey MA, Versi E. Predictive value of clinical evaluation of stress urinary incontinence: a summary of the published literature. Int Urogynecol J Pelvic Floor Dysfunct. 2001;12:31-7.
25. Fantl AJ. Urinary incontinence in adults: acute and chronic management/urinary incontinence in adults. Guideline Panel Update. Rockville, Md.: US Department of Health and Human Services, 1996. Agency for Health Care Policy and Research; Clinical Practice Guideline Number 2: AHCPR publication no. 96-0682.
26. Norton PA, Zinner NR, Yalcin I, Bump RC. Duloxetine Urinary Incontinence Study Group. Duloxetine versus placebo in the treatment of stress urinary incontinence. Am J Obstet Gynecol 2002;187:40-8.
27. Zinner N, Dmochoswski R, Miklos J, Norton P, Yalcin I, Bump R. Duloxetine versus placebo in the treatment of stress urinary incontinence. Neurourol Urodyn 2002;21:383-4.
28. Bø K. Pelvic floor muscle exercise for the treatment of stress urinary incontinence. An exercise physiology perspective. Int Urogynecol J 1995; 6:282-91.
29. Bø K, Hagen RH, Kvarstein B, Jorgensen J, Larsen S. Pelvic floor muscle exercise for the treatment of female stress urinary incontinence: III. Effects of two different degrees of pelvic floor muscle exercises. Neurouro & Urodyn 1990;9:489-502.
30. Miller JM, Ashton-Miller A DeLancey JO. A pelvic muscle precontraction can reduce cough-related urine loss' in selected women with mild SUI. J Am Geriatr Soc 1998;46:870-4.
31. Berghmans LC, Hendriks HJ, Bo K, Hay-Smith EJ, De Bie RA, Van Waalwijk van Doorn ES. Conservative treatment of stress urinary incontinence in women: a systematic review of randomized clinical trials. Br J Urol 1998;82:181-91.
32. Hay-Smith EJC, Bø K, Berghmans LCM, Hendriks HJM, De Bie RA, Van Waalwijk van Doorn ESC. Pelvic floor muscle training for urinary incontinence in women (Cochrane Review). En: The Cochrane Library, Oxford, 2001, Issue 1.
33. Zorzitto ML, Holliday PJ, Jewett MA, Herschorn S, Fernie GR. Oxybutynin chloride for geriatric urinary dysfunction: a double-blind placebo-controlled study. Age Ageing 1989;18:195-200.
34. Moore KH, Hay DM, Imrie AE, Watson A, Goldstein M. Oxybutynin hydrochloride (3 mg) in the treatment of women with idiopathic detrusor instability. Br J Urol 1990;66:479-85.
35. Madersbacher H, Stohrer M, Richter R, Burgdorfer H, Hachen HJ, Murtz G. Trospium chloride versus oxybutynin: a randomized, double-blind, multicentre trial in the treatment of detrusor hyper-reflexia. Br J Urol 1995;75:452-6.
36. Cardozo L, Chapple CR, Toozs-Hobson P, Grosse-Freese M, Bulitta M, Lehmacher W, et al. Efficacy of trospium chloride in patients with detrusor instability: a placebo-controlled, randomized, double-blind, multicentre clinical trial. BJU Int 2000;85:659-64.
37. Abrams P, Malone-Lee J, Jacquetin B, Wyndaele JJ, Tammela T, Jonas U, et al.Twelve-month treatment of overactive bladder: efficacy and tolerability of tolterodine. Drugs Aging 2001;18:551-60.
38. Malone-Lee JG, Walsh JB, Maugourd MF. Tolterodine: a safe and effective treatment for older patients with overactive bladder. J Am Geriatr Soc 2001;49:700-5.
39. Appell RA, Abrams P, Drutz HP, Van Kerrebroeck PE, Millard R, Wein A. Tolterodine: superior tolerability than and comparable efficacy to oxybutynin in individuals 50 years old or older with overactive bladder: a randomized controlled trial. J Urol 2001;165:1452-6.
40. Van Kerrebroeck PE, Amarenco G, Thuroff JW, Madersbacher HG, Lock MT, Messelink EJ, et al. Dose-ranging study of tolterodine in patients with detrusor hyperreflexia. Neurourol Urodyn 1998;17:499-512.
41. Burgio KL, Locher JL, Goode PS, Hardin JM, McDowell BJ, Dombrowski M, et al. Behavioral vs drug treatment for urge urinary incontinence in older women: a randomized controlled trial. JAMA 1998;280:1995-2000.
42. Fantl JA, Wyman JF, McClish DK, Harkins SW, Elswick RK, Taylor JR, et al. Efficacy of bladder training in odler women with urinary incontinence. JAMA 1991;265:609-13.
43. Jarvis GJ. A controlled trial bladder drill and drug therapy in management of detrusor instability. Br J Urol 1981;53:565-6.
44. Colombo M, Zanetta G, Scalambrino S, Milani R. Oxybutinin and bladder training in the management of female urinary urge incontinence: A randomized study. Int Urogynecol J 1995;6:63-7.